QQ客服 官方微博 反馈留言

	Targeting EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) resistance mutations in NSCLC: Current developments in medicinal chemistry
	Lu, Xiaoyun[1]; Yu, Lei[2]; Zhang, Zhang[1]; Ren, Xiaomei[1]; Smaill, Jeff B.[3,4]; Ding, Ke[1]
	2018
卷号	38期号:5页码:1550
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4297024
专题	暨南大学
作者单位	1.[1]Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China 3.[3]Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand 4.[4]Univ Auckland, Auckland Canc Soc, Res Ctr, Auckland, New Zealand
推荐引用方式 GB/T 7714	Lu, Xiaoyun[1],Yu, Lei[2],Zhang, Zhang[1],et al. Targeting EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) resistance mutations in NSCLC: Current developments in medicinal chemistry[J],2018,38(5):1550.
APA	Lu, Xiaoyun[1],Yu, Lei[2],Zhang, Zhang[1],Ren, Xiaomei[1],Smaill, Jeff B.[3,4],&Ding, Ke[1].(2018).Targeting EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) resistance mutations in NSCLC: Current developments in medicinal chemistry.,38(5),1550.
MLA	Lu, Xiaoyun[1],et al."Targeting EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) resistance mutations in NSCLC: Current developments in medicinal chemistry".38.5(2018):1550.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。